[28PS1-am] Development of novel medicines and formulations

Tue. Mar 28, 2023 11:10 AM - 12:10 PM [Room PS1] (1F)

Chair: Kousei Ito, Tomohiro Omura

+Add all to schedule

11:10 AM - 11:22 AM

[28PS1-am01S] Rebamipide nanogel formulation based on gum arabic and carboxy vinyl polymer provides early therapy of oral mucositis

○Saori Deguchi¹, Miku Nishida¹, Miri Komatsu¹, Hikaru Wakuda¹, Hiroko Otake¹, Noriaki Nagai¹ (1. Pharm., Kindai Univ.)

11:22 AM - 11:34 AM

[28PS1-am02S] The evaluation of the growth inhibitory effect of Streptococcus mutans using fluoride-containing oral patch

○Himawari Kimura¹, Yoichi Yamada², Eiichi Toorisaka³, Joma Ito¹, Akari Kawanaka¹, Humina Yano¹, Hiroshige Ono¹ (1. Sanyo-Onoda City University, 2. Shujitsu University, 3. Yamaguchi University)

11:34 AM - 11:46 AM

[28PS1-am03S] Improved oral absorption of cannabidiol by solid lipid nanoparticles

○Monami Sugihara¹, Kohei Yamada¹, Hideyuki Sato¹, Robert K. Prud’homme², Satomi Onoue¹ (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. Princeton Univ.)

11:46 AM - 11:58 AM

[28PS1-am04S] Development of dry powder inhaler of meloxicam for the treatment of airway inflammatory diseases

○Kazuki Masui¹, Atsushi Uchida^1,2, Kohei Yamada¹, Hideyuki Sato¹, Satomi Onoue¹ (1. Sch. Pharm. Sci., Univ. Shizuoka., 2. Dept. Pharm., Univ. Yamanashi Hosp.)

11:58 AM - 12:10 PM

[28PS1-am05S] Invention of the Bispecific T-cell Engager antibody based cyclic single-chain antibodies and evaluation for drug design development

○Mizuki Ogawa¹, Mana Namikawa², Shosei Kai², Yifan Yang¹, Rui Shi¹, Takashi Sato¹, Yoshihiro Kobashikawa¹, Hiroshi Morioka¹ (1. Grad.Sch.Pharm.Sci.,Kumamoto Univ., 2. Sch.Pharm.Kumamoto Univ.)

Session information